{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:58:36Z","timestamp":1775473116142,"version":"3.50.1"},"reference-count":38,"publisher":"Medical Association of Zenica-Doboj","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicinski Glasnik"],"published-print":{"date-parts":[[2020,7,12]]},"abstract":"<jats:p>&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Aim&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt; To evaluate a correlation of serum level of neutrophil gelatinase-associated lipocalin (NGAL) to the risk of the occurrence of complications in patients with the early phase of ST-segment elevation myocardical infarction (STEMI) treated with fibrinolytic therapy prior to percutaneous coronary intervention (PCI). &amp;lt;br \/&amp;gt;&amp;lt;strong&amp;gt;Methods&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt; A total of 54 patients with the diagnosis of STEMI treated with fibrinolytic therapy (alteplase) prior to PCI were included. Patients were admitted to the Intensive Care Unit (ICU) of Clinic for Heart, Blood Vessel and Rheumatic Diseases in the period January to March 2018. All patients underwent coronary angiography and PCI within the maximum of 48 hours delay after fibrinolysis, according to the hemodynamic and electrical stability and PCI availability. Blood samples were taken immediately after admission prior to fibrinolytic administration. Patients were divided into two groups according to NGAL values (less or more than 134.05 ng\/mL). &amp;lt;br \/&amp;gt;&amp;lt;strong&amp;gt;Results&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt; Higher values of NGAL have effect on a higher mean systolic and diastolic pressure (p=0.001 and p=0.003, respectively). Patients with higher NGAL values also have higher values of brain natriuretic peptide (p=0.0001) and highly sensitive troponin I (p=0.002). In that group relative risk (RR) for lethal outcome was 6.4 times significantly higher (p=0.002), for the development of heart failure 2.88 times (p=0.0002), for post-myocardial infarction angina pectoris 2.24 times (p=0.0158), and for ventricular rhythm disturbances (ventricular tachycardia, ventricular fibrillation) 1.96 times higher (p=0.0108). &amp;lt;br \/&amp;gt;&amp;lt;strong&amp;gt;Conclusion&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt; Increased NGAL value is related to an unfavourable outcome of patients in the early phase of STEMI treated with fibrinolytic therapy prior to PCI.&amp;lt;\/p&amp;gt;<\/jats:p>","DOI":"10.17392\/1139-20","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T10:28:16Z","timestamp":1713695296000},"page":"328-334","source":"Crossref","is-referenced-by-count":1,"title":["Neutrophil gelatinase-associated lipocalin is a predictor of complications in the early phase of ST-elevation myocardial infarction"],"prefix":"10.17392","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3749-6073","authenticated-orcid":false,"given":"Nirvana","family":"\u0160abanovi\u0107-Bajramovi\u0107","sequence":"first","affiliation":[{"name":"Clinical Centre University of Sarajevo","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Intensive Care Unit, Clinic for Heart, Blood Vessel and Rheumatic Diseases"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enisa","family":"Hod\u017ei\u0107","sequence":"additional","affiliation":[{"name":"Clinical Centre University of Sarajevo","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Intensive Care Unit, Clinic for Heart, Blood Vessel and Rheumatic Diseases"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer","family":"Iglica","sequence":"additional","affiliation":[{"name":"Clinical Centre University of Sarajevo","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Intensive Care Unit, Clinic for Heart, Blood Vessel and Rheumatic Diseases"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edin","family":"Begi\u0107","sequence":"additional","affiliation":[{"name":"General Hospital ''Prim.dr. Abdulah Naka\u0161\"","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Department of Cardiology"]},{"name":"School of Medicine, Sarajevo School of Science and Technology","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Department of Pharmacology"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerma","family":"Resi\u0107","sequence":"additional","affiliation":[{"name":"Clinical Centre University of Sarajevo","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Intensive Care Unit, Clinic for Heart, Blood Vessel and Rheumatic Diseases"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenana","family":"Aganovi\u0107","sequence":"additional","affiliation":[{"name":"Clinical Centre University of Sarajevo","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Intensive Care Unit, Clinic for Heart, Blood Vessel and Rheumatic Diseases"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirela","family":"Halil\u010devi\u0107","sequence":"additional","affiliation":[{"name":"Clinical Centre University of Sarajevo","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Intensive Care Unit, Clinic for Heart, Blood Vessel and Rheumatic Diseases"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senad","family":"Bajramovi\u0107","sequence":"additional","affiliation":[{"name":"Clinical Centre of the University of Sarajevo","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Urology Clinic"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"49509","published-online":{"date-parts":[[2020,7,12]]},"reference":[{"key":"ref1","first-page":"374","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL): validation of commercially available ELISA","author":"KPedersenK","year":"2010","unstructured":"Pedersen KR, Ravn HB, Hjortdal VE, N\u00f8rregaard \nR, Povlsen JV. Neutrophil gelatinase-associated lipo-\ncalin (NGAL): validation of commercially available \nELISA. Scand J Clin Lab Invest 2010; 70:374-82.","journal-title":"Scand J Clin Lab Invest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/0004563214521795","article-title":"Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status","author":"AHaase-FielitzA","year":"2014","unstructured":"Haase-Fielitz A, Haase M, Devarajan P. Neutrophil \ngelatinase-associated lipocalin as a biomarker of \nacute kidney injury: a critical evaluation of current \nstatus. Ann Clin Biochem 2014; 51:335-51.","journal-title":"Ann Clin Biochem"},{"key":"ref3","first-page":"211","article-title":"Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance","author":"DMcilroyD","year":"2010","unstructured":"McIlroy DR, Wagener G, Lee HT. Neutrophil gela-\ntinase-associated lipocalin and acute kidney injury \nafter cardiac surgery: the effect of baseline renal \nfunction on diagnostic performance. Clin J Am Soc \nNephrol 2010; 5:211-9.","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijcard.2007.04.048","article-title":"NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine?","author":"HBachorzewska-GajewskaH","year":"2008","unstructured":"Bachorzewska-Gajewska H, Malyszko J, Sit-\nniewska E, Malyszko JS, Poniatowski B, Pawlak \nK, Dobrzycki S. NGAL (neutrophil gelatinase-asso-\nciated lipocalin) and cystatin C: are they good pre-\ndictors of contrast nephropathy after percutaneous \ncoronary interventions in patients with stable angina \nand normal serum creatinine? Int J Cardiol 2008; \n127:290-1.","journal-title":"Int J Cardiol"},{"key":"ref5","first-page":"35","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections","author":"RBarretoR","year":"2014","unstructured":"Barreto R, Elia C, Sol\u00e0 E, Moreira R, Ariza X, Ro-\ndr\u00edguez E, Graupera I, Alfaro I, Morales-Ruiz M, \nPoch E, Guevara M1 Fern\u00e1ndez J, Jim\u00e9nez W, \nArroyo V, Gin\u00e8s P. Urinary neutrophil gelatinase-\nassociated lipocalin predicts kidney outcome and de-\nath in patients with cirrhosis and bacterial infections. \nJ Hepatol 2014; 61:35-42.","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","author":"EVernaE","year":"2012","unstructured":"Verna EC, Brown RS, Farrand E, Pichardo EM, For-\nster CS, Sola-Del Valle DA, Adkins SH, Sise ME, \nOliver JA, Radhakrishnan J, Barasch JM, Nickolas \nTL.Urinary neutrophil gelatinase-associated lipo-\ncalin predicts mortality and identifies acute kidney \ninjury in cirrhosis. Dig Dis Sci 2012; 57:2362-70.","journal-title":"Dig Dis Sci"},{"key":"ref7","first-page":"612032","article-title":"NGAL and metabolomics: the single biomarker to reveal the metabolome alterations in kidney injury","author":"ANotoA","year":"2013. 2013","unstructured":"Noto A, Cibecchini F, Fanos V, Mussap M. NGAL \nand metabolomics: the single biomarker to reveal \nthe metabolome alterations in kidney injury. Biomed \nRes Int 2013; 2013:612032.","journal-title":"Biomed Res Int"},{"key":"ref8","first-page":"2534","article-title":"Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury","author":"JMishraJ","year":"2003","unstructured":"Mishra J, Qing MA, Prada A, Mitsnefes M, Zahedi \nK, Yang J, Barasch J, Devarajan P.. Identification of \nneutrophil gelatinase-associated lipocalin as a novel \nearly urinary biomarker for ischemic renal injury. J \nAm Soc Nephrol 2003; 14:2534-43.","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.cca.2012.07.010","article-title":"Natriuretic peptides and NGAL in heart failure: does a link exist?","author":"APalazzuoliA","year":"2012","unstructured":"Palazzuoli A, Beltrami M, Pellegrini M, Nuti R. Na-\ntriuretic peptides and NGAL in heart failure: does a \nlink exist? Clin Chim Acta 2012; 413:1832-8.","journal-title":"Clin Chim Acta"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cardfail.2009.07.003","article-title":"Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure","author":"AAghelA","year":"2010","unstructured":"Aghel A, Shrestha K, Mullens W, Borowski A, Tang \nWH. Serum neutrophil gelatinase-associated lipoca-\nlin (NGAL) in predicting worsening renal function \nin acute decompensated heart failure. J Card Fail \n2010; 16:49-54.","journal-title":"J Card Fail"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCHEARTFAILURE.113.000242","article-title":"Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure","author":"VVan DeursenV","year":"2014","unstructured":"van Deursen VM, Damman K, Voors AA, van der \nWal MH, Jaarsma T, van Veldhuisen DJ, Hillege \nHL. Prognostic value of plasma neutrophil gelatina-\nse-associated lipocalin for mortality in patients with \nheart failure. Circ Heart Fail 2014; 7:35-42.","journal-title":"Circ Heart Fail"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12872-015-0054-9","article-title":"The role of urine neutrophil gelatinase--associated lipocalin (NGAL) in acute heart failure in patients with ST--elevation myocardial infarction","author":"SKirbisS","year":"2015","unstructured":"Kirbis S, Gorenjak M, Sinkovic A. The role of urine \nneutrophil gelatinase--associated lipocalin (NGAL) \nin acute heart failure in patients with ST--elevati-\non myocardial infarction. BMC Cardiovasc Disord \n2015; 15:49.","journal-title":"BMC Cardiovasc Disord"},{"key":"ref13","first-page":"20","article-title":"The Central Role of Neutrophil Gelatinase-Associated Lipocalin in Cardiovascular Fibrosis","author":"JLeopoldJ","year":"2015","unstructured":"Leopold JA. The Central Role of Neutrophil Gelati-\nnase-Associated Lipocalin in Cardiovascular Fibro-\nsis. Hypertension 2015; 66:20-2.","journal-title":"Hypertension"},{"key":"ref14","first-page":"339","article-title":"Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention","author":"SLindbergS","year":"2012","unstructured":"Lindberg S, Pedersen SH, Mogelvang R, Jensen \nJS, Flyvbjerg A, Galatius S, Magnusson NE. Pro-\ngnostic utility of neutrophil gelatinase-associated \nlipocalin in predicting mortality and cardiovascu-\nlar events in patients with ST-segment elevation \nmyocardial infarction treated with primary percuta-\nneous coronary intervention. J Am Coll Cardiol \n2012; 60:339-45.","journal-title":"J Am Coll Cardiol"},{"key":"ref15","first-page":"509204","article-title":"Laboratory markers of ventricular arrhythmia risk in renal failure","author":"IMozosI","year":"2014. 2014","unstructured":"Mozos I. Laboratory markers of ventricular \narrhythmia risk in renal failure. Biomed Res Int \n2014; 2014:509204.","journal-title":"Biomed Res Int"},{"key":"ref16","first-page":"111","author":"JElmerJ","year":"2016","unstructured":"Elmer J, Jeong K, Abebe KZ, Guyette FX, Murugan \nR, Callaway CW, Rittenberger JC; Pittsburgh Post-\nCardiac Arrest Service. Serum Neutrophil Gelati-\nnase-Associated Lipocalin Predicts Survival After \nResuscitation From Cardiac Arrest. Crit Care Med \n2016; 44:111-9.","journal-title":"Crit Care Med"},{"key":"ref17","first-page":"76","article-title":"Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension","author":"FGharishvandiF","year":"2015","unstructured":"Gharishvandi F, Kazerouni F, Ghanei E, Rahimipour \nA, Nasiri M. Comparative assessment of neutrophil \ngelatinase-associated lipocalin (NGAL) and cystatin \nC as early biomarkers for early detection of renal \nfailure in patients with hypertension. Iran Biomed J \n2015; 19:76-81.","journal-title":"Iran Biomed J"},{"key":"ref18","first-page":"114","article-title":"Urinary NGAL-Positive Acute Kidney Injury and Poor Long-term Outcomes in Hospitalized Patients","author":"ESingerE","year":"2016","unstructured":"Singer E, Schrezenmeier EV, Elger A, Seelow ER, \nKrannich A, Luft FC, Schmidt-Ott KM. Urinary \nNGAL-Positive Acute Kidney Injury and Poor \nLong-term Outcomes in Hospitalized Patients. Kid-\nney Int Rep 2016; 1:114-24.","journal-title":"Kidney Int Rep"},{"key":"ref19","first-page":"4153","article-title":"Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin","author":"AEirinA","year":"2012","unstructured":"Eirin A, Gloviczki ML, Tang H, Rule AD, Woollard \nJR, Lerman A, Textor SC, Lerman LO. Chronic re-\nnovascular hypertension is associated with elevated \nlevels of neutrophil gelatinase-associated lipoca-\nlin. Nephrol Dial Transplant 2012; 27:4153-61.","journal-title":"Nephrol Dial Transplant"},{"key":"ref20","first-page":"205848","article-title":"Plasma neutrophil gelatinase-associated lipocalin is independently associated with left ventricular hypertrophy and diastolic dysfunction in patients with chronic kidney disease","author":"IKimI","year":"2018","unstructured":"Kim IY, Kim JH, Kim MJ, Lee DW, Hwang CG, Han \nM, Rhee H, Song SH, Seong EY, Lee SB. Plasma ne-\nutrophil gelatinase-associated lipocalin is indepen-\ndently associated with left ventricular hypertrophy \nand diastolic dysfunction in patients with chronic \nkidney disease. PLoS One 2018; 13:e0205848.","journal-title":"PLoS One"},{"key":"ref21","first-page":"4582","article-title":"Prognostic value of urinary neutrophil gelatinase-associated lipocalin on the first day of admission for adverse events in patients with acute decompensated heart failure","author":"YNakadaY","year":"2017","unstructured":"Nakada Y, Kawakami R, Matsui M, Ueda T, Nakano \nT, Takitsume A, Nakagawa H, Nishida T, Onoue K, \nSoeda T, Okayama S, Watanabe M, Kawata H, Oku-\nra H, Saito Y. Prognostic value of urinary neutrophil \ngelatinase-associated lipocalin on the first day of \nadmission for adverse events in patients with acu-\nte decompensated heart failure. J Am Heart Assoc \n2017; 6:e004582","journal-title":"J Am Heart Assoc"},{"key":"ref22","first-page":"1420","article-title":"Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKI-NESIS Study","author":"AMaiselA","year":"2016","unstructured":"Maisel AS, Wettersten N, van Veldhuisen DJ, Mu-\neller C, Filippatos G, Nowak R, Hogan C, Kontos \nMC, Cannon CM, M\u00fcller GA, Birkhahn R, Clopton \nP, Taub P, Vilke GM, McDonald K, Mahon N, Nu\u00f1ez \nJ, Briguori C, Passino C, Murray PT. Neutrophil ge-\nlatinase-associated lipocalin for acute kidney injury \nduring acute heart failure hospitalizations: the AKI-\nNESIS Study. J Am Coll Cardiol 2016; 68:1420-31.","journal-title":"J Am Coll Cardiol"},{"key":"ref23","first-page":"10","article-title":"Prognostic value of neutrophil gelatinase-associated lipocalin in predicting in-hospital complications in patients with st-segment elevation myocardial infarction","author":"Al-AfifyAaAl-Afify","year":"2013","unstructured":"Al-Afify AA. Prognostic value of neutrophil gela-\ntinase-associated lipocalin in predicting in-hospital \ncomplications in patients with st-segment elevation \nmyocardial infarction. Research Journal of Cardio-\nlogy 2013; 6:10-8.","journal-title":"Research Journal of Cardiology"},{"key":"ref24","first-page":"189797","article-title":"Serum levels of gelatinase associated lipocalin as indicator of the inflammatory status in coronary artery disease","author":"NKafkasN","year":"2012","unstructured":"Kafkas N, Demponeras C, Zoubouloglou F, Spanou \nD, Babalis D, Makris K. Serum levels of gelatinase \nassociated lipocalin as indicator of the inflammatory \nstatus in coronary artery disease. Int J Inflammation \n2012; 189797","journal-title":"Int J Inflammation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2310\/JIM.0b013e31823e9d86","article-title":"Prognostic significance of neutrophil gelatinase-associated lipocalin in ST-segment elevation myocardial infarction","author":"AAkcayA","year":"2012","unstructured":"Akcay AB, Ozlu MF, Sen N, Cay S, Ozturk OH. Pro-\ngnostic significance of neutrophil gelatinase-asso-\nciated lipocalin in ST-segment elevation myocardial \ninfarction. J Invset Med 2012; 60:508-13.","journal-title":"J Invset Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e1056","DOI":"10.1371\/journal.pone.0001056","article-title":"Neutrophil activation status in stable coronary artery disease","author":"ESarndahlE","year":"2007","unstructured":"Sarndahl E, Bergstrom I, Brodin VP, Nijm J, Sette-\nrud HL, Jonasson L. Neutrophil activation status \nin stable coronary artery disease. PLoS One 2007; \n2:e1056.","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/eurheartj\/ehp088","article-title":"Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure","author":"AYndestadA","year":"2009","unstructured":"Yndestad A, Landr\u00f8 L, Ueland T, Dahl CP, Flo TH, \nVinge LE, Espevik T, Fr\u00f8land SS, Husberg C, Chri-\nstensen G, Dickstein K, Kjekshus J, \u00d8ie E, Gullestad \nL, Aukrust P. Increased systemic and myocardial \nexpression of neutrophil gelatinase-associated lipo-\ncalin in clinical and experimental heart failure. Eur \nHeart J 2009; 30:1229-36.","journal-title":"Eur Heart J"},{"key":"ref28","first-page":"1101","article-title":"Plasma neutrophil gelatinaseassociated lipocalin is independently associated with cardiovascular disease and mortality in communitydwelling older adults: The Rancho Bernardo Study","author":"LDanielsL","year":"2012","unstructured":"Daniels LB, Barrett-Connor E, Clopton P, Laughlin \nGA, Ix JH, Maisel AS. Plasma neutrophil gelatinase-\nassociated lipocalin is independently associated with \ncardiovascular disease and mortality in community-\ndwelling older adults: The Rancho Bernardo Stu-\ndy. J Am Coll Cardiol 2012; 59:1101-9.","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/HYPERTENSIONAHA.117.09791","article-title":"Aldosterone target NGAL (neutrophil gelatinase-associated lipocalin) is involved in cardiac remodeling after myocardial infarction through NF\u03baB pathway","author":"EMart\u00ednez-Mart\u00ednezE","year":"2017","unstructured":"Mart\u00ednez-Mart\u00ednez E, Buonafine M, Boukhalfa I, \nIbarrola J, Fern\u00e1ndez-Celis A, Kolkhof P, Rossignol \nP, Girerd N, Mulder P, L\u00f3pez-Andr\u00e9s N, Ouvrard-\nPascaud A, Jaisser F. Aldosterone target NGAL \n(neutrophil gelatinase-associated lipocalin) is invol-\nved in cardiac remodeling after myocardial infarc-\ntion through NF\u03baB pathway. Hypertension 2017; \n70:1148-56.","journal-title":"Hypertension"},{"key":"ref30","first-page":"5971","article-title":"Experimental and human evidence for lipocalin-2 (neutrophil gelatinase-associated lipocalin [NGAL]) in the development of cardiac hypertrophy and heart failure","author":"FMarquesF","year":"2017","unstructured":"Marques FZ, Prestes PR, Byars SG, Ritchie SC, \nW\u00fcrtz P, Patel SK, Booth SA, Rana I, Minoda Y, \nBerzins SP, Curl CL, Bell JR, Wai B, Srivastava PM, \nKangas AJ, Soininen P, Ruohonen S, K\u00e4h\u00f6nen M, \nLehtim\u00e4ki T, Raitoharju E, Havulinna A, Perola M, \nRaitakari O, Salomaa V, Ala-Korpela M, Kettunen \nJ, McGlynn M, Kelly J, Wlodek ME, Lewandowski \nPA, Delbridge LM, Burrell LM, Inouye M, Harrap \nSB, Charchar FJ. Experimental and human eviden-\nce for lipocalin-2 (neutrophil gelatinase-associated \nlipocalin [NGAL]) in the development of cardiac \nhypertrophy and heart failure. J Am Heart Assoc \n2017; 6:e005971.","journal-title":"J Am Heart Assoc"},{"key":"ref31","first-page":"38","article-title":"Lipocalin-2 in Stroke","author":"WChouW","year":"2015","unstructured":"Chou WH, Wang G, Kumar V, Weng YC. Lipoca-\nlin-2 in Stroke. Neuro 2015;2:38-41.","journal-title":"Neuro"},{"key":"ref32","first-page":"202","article-title":"The different molecular forms of urine neutrophil gelatinase-associated lipocalin present in dogs with urinary diseases","author":"WHsuW","year":"2014","unstructured":"Hsu WL, Chiou HC, Tung KC, Belot G, Virilli A, \nWong ML, Lin FY, Lee YJ. The different molecular \nforms of urine neutrophil gelatinase-associated lipo-\ncalin present in dogs with urinary diseases. BMC Vet \nRes 2014; 10:202.","journal-title":"BMC Vet Res"},{"key":"ref33","first-page":"2229","article-title":"The origin of multiple molecular forms in urine of HNL\/ NGAL","author":"LCaiL","year":"2010","unstructured":"Cai L, Rubin J, Han W, Venge P, Xu S. The ori-\ngin of multiple molecular forms in urine of HNL\/ \nNGAL. Clin J Am Soc Nephrol 2010; 5:2229-35","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref34","first-page":"796","article-title":"Neutrophil gelatinase -associated lipocalin (NGAL), pro-matrix metalloproteinase-9 (pro-MMP-9) and their complex pro-MMP-9\/ NGAL in leukaemias","author":"SBouchetS","year":"2014","unstructured":"Bouchet S, Bauvois B. Neutrophil gelatinase -asso-\nciated lipocalin (NGAL), pro-matrix metalloprotei-\nnase-9 (pro-MMP-9) and their complex pro-MMP-9\/ \nNGAL in leukaemias. Cancers 2014; 6:796-812.","journal-title":"Cancers"},{"key":"ref35","first-page":"1160","article-title":"Neutrophil gelatinase-associated lipocalin: a more specific assay is needed for diagnosing renal injury","author":"GLippiG","year":"2012","unstructured":"Lippi G, Cervellin G. Neutrophil gelatinase-asso-\nciated lipocalin: a more specific assay is needed \nfor diagnosing renal injury. Clin Chim Acta 2012; \n413:1160-1.","journal-title":"Clin Chim Acta"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1189\/jlb.1106671","article-title":"Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment","author":"ALeclercqA","year":"2007","unstructured":"Leclercq A, Houard X, Philippe M, Ollivier V, \nSebbag U, Meilhac O, Michel J-B. Involvement of \nintraplaque hemorrhage in atherothrombosis evolu-\ntion via neutrophil protease enrichment. J Leukoc \nBiol 2007; 82:1420-9.","journal-title":"J Leukoc Biol"},{"key":"ref37","first-page":"136","article-title":"Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction","author":"AHemdahlA","year":"2006","unstructured":"Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, He-\ndin U, Kastrup J, Thor\u00e9n P, Hansson GK. Expression \nof neutrophil gelatinase-associated lipocalin in athe-\nrosclerosis and myocardial infarction. Arterioscler \nThromb Vasc Biol 2006; 26:136-42.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref38","first-page":"623","article-title":"Diagnostic and prognostic utility of neutrophil gelatinase-associated lipocalin (NGAL) in patients with cardiovascular diseases -review","author":"KHelanovaK","year":"2014","unstructured":"Helanova K, Spinar J, Parenica J. Diagnostic and \nprognostic utility of neutrophil gelatinase-associated \nlipocalin (NGAL) in patients with cardiovascular \ndiseases -review. Kidney Blood Press Res 2014; \n39:623-9.","journal-title":"Kidney Blood Press Res"}],"container-title":["Medicinski Glasnik"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medicinskiglasnik.ba\/article\/162\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicinskiglasnik.ba\/article\/162\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:44:58Z","timestamp":1775468698000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicinskiglasnik.ba\/article\/id\/397\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,12]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,7,12]]},"published-print":{"date-parts":[[2020,7,12]]}},"URL":"https:\/\/doi.org\/10.17392\/1139-20","archive":["Internet Archive"],"relation":{},"ISSN":["1840-0132","1840-0132"],"issn-type":[{"value":"1840-0132","type":"electronic"},{"value":"1840-0132","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,12]]}}}